Patent · US Active

In vivo transduction with a chimeric AAV capsid protein

US8906387B2 · kind B2 · utility

45Cited by

40References

1Claims

0Family size

Assignee

The Board of Trustees of the Leland Stanford Junior University · US

Inventors

Mark A. Kay · Los Altos, US
Dirk Grimm · Palo Alto, US

Key dates

Filing date	May 15, 2012
Grant date	Dec 9, 2014
Priority date	—
Expiry date	May 15, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Recombinant adeno-associated viral (AAV) capsid proteins are provided. Methods for generating a library of recombinant adeno-associated viral capsid proteins are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.